Stocks · Health care · Pharmaceutical Preparations

Ovid Therapeutics Inc.

OVID Clue Score44
United States Fiscal year ends December CIK 0001636651 Results filed 18 Mar 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Jeffrey A Rona
23 Feb 2026
Cbfo
Sell
8,541
$1.45
$12.38K
Margaret A. Alexander
23 Feb 2026
President and CEO
Sell
11,656
$1.45
$16.90K
Jeffrey A Rona
26 Feb 2025
Cbfo
Sell
3,902
$0.56
$2.19K
Margaret A. Alexander
26 Feb 2025
President and COO
Sell
5,279
$0.56
$2.96K
Jason Tardio
12 Sep 2022
Chief Operating Officer
Sell
17,344
$2.15
$37.29K

What was left out

Form 4 filings counted 157
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 14,846,701
Sales filed before the plan box existed 1
History held since 10 May 2017